Bioequivalence of Two Formulations of Gliclazide in a Randomized Crossover Study in Healthy Caucasian Subjects Under Fasting Conditions-Reference-Cited by-同舟云学术

Bioequivalence of Two Formulations of Gliclazide in a Randomized Crossover Study in Healthy Caucasian Subjects Under Fasting Conditions

Published:2018-03-26 Issue:1 Volume:8 Page:16-21
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Pop Diana Ioana¹²,Oroian Monica¹²,Bhardwaj Sandeep²,Marcovici Adriana²,Khuroo Arshad³,Kochhar Ravi⁴,Vlase Laurian¹

Affiliation:

1. Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy; University of Medicine and Pharmacy “Iuliu Haţieganu,”; Cluj-Napoca Romania

2. Clinical Pharmacology and Pharmacokinetics Department; Terapia S.A- a Sun Pharma Company; Cluj-Napoca Romania

3. Clinical Pharmacology and Pharmacokinetics Department; Gurugram India

4. R&D Formulation Development; Gurugram India

Funder

Ranbaxy Laboratories Limited

Sun Pharmaceutical Industries

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpdd.445/fullpdf

Reference11 articles.

1. Type 2 diabetes-therapeutic guide for general practitioners;Ionescu;RJDNMD,2006

2. Gliclazide modified release: its place in the therapeutic armamentarium;Crepaldi;Metabolism,2000

3. Differential sensitivity of beta-cell and extrapancreatic K(ATP) channels to gliclazide;Gribble;Diabetologia,1999

4. Solubility and dissolution proprieties of gliclazide;Demirturk;FABAD J Pharm Sci,2004

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gliclazide enhances exercise performance and recovery of muscle strength in healthy trained individuals: a randomized controlled trial;2024-06-13

2. Optimal dosing of gliclazide—A model‐based approach;Basic & Clinical Pharmacology & Toxicology;2023-04-22

3. Kinetics of gliclazide after single dose oral administration of gliclazide 60 mg modified release tablet;Studia Universitatis Babeș-Bolyai Chemia;2020-06-30

4. The relative bioavailability of two formulations containing 10 mg Dapagliflozin assessed under fasting conditions in a randomized crossover study in healthy Caucasian subjects;Acta Marisiensis - Seria Medica;2020-03-01

5. RELATIVE BIOAVAILABILITY OF TWO FORMULATIONS CONTAINING DAPAGLIFLOZIN 10 MG UNDER FED CONDITION IN A RANDOMIZED CROSSOVER STUDY IN HEALTHY CAUCASIAN SUBJECTS;FARMACIA;2020-02-25